KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+7.79%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$324M
AUM Growth
+$324M
Cap. Flow
-$9.47M
Cap. Flow %
-2.92%
Top 10 Hldgs %
98.19%
Holding
14
New
–
Increased
4
Reduced
8
Closed
2

Top Buys

1
EXEL icon
Exelixis
EXEL
$5.08M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
$1.85M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
$254K
4
VNDA icon
Vanda Pharmaceuticals
VNDA
$244K

Top Sells

1
MCK icon
McKesson
MCK
$10.8M
2
UTHR icon
United Therapeutics
UTHR
$2.32M
3
BIIB icon
Biogen
BIIB
$2.12M
4
REGN icon
Regeneron Pharmaceuticals
REGN
$567K
5
CAH icon
Cardinal Health
CAH
$307K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$13.8B
$53.4M 16.5% 192,048 -8,359 -4% -$2.32M
BIIB icon
2
Biogen
BIIB
$19.4B
$49M 15.15% 177,004 -7,644 -4% -$2.12M
REGN icon
3
Regeneron Pharmaceuticals
REGN
$61.5B
$43.4M 13.4% 60,103 -786 -1% -$567K
ALKS icon
4
Alkermes
ALKS
$4.78B
$36.6M 11.32% 1,401,783 -9,899 -0.7% -$259K
EXEL icon
5
Exelixis
EXEL
$10.1B
$34.3M 10.6% 2,138,039 +316,564 +17% +$5.08M
ENTA icon
6
Enanta Pharmaceuticals
ENTA
$180M
$27.7M 8.55% 594,818 +5,458 +0.9% +$254K
EMBC icon
7
Embecta
EMBC
$847M
$25.7M 7.95% 1,017,657 -6,543 -0.6% -$165K
CAH icon
8
Cardinal Health
CAH
$35.5B
$25.6M 7.9% 332,749 -3,993 -1% -$307K
TARO
9
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$18.7M 5.78% 644,664 +63,871 +11% +$1.85M
EGRX
10
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.36M 1.04% 114,825 -6,258 -5% -$183K
KOD icon
11
Kodiak Sciences
KOD
$478M
$3.32M 1.03% 463,598 -5,790 -1% -$41.5K
VNDA icon
12
Vanda Pharmaceuticals
VNDA
$279M
$2.55M 0.79% 345,290 +32,991 +11% +$244K
MCK icon
13
McKesson
MCK
$85.4B
– – -31,913 Closed -$10.8M
NXTC icon
14
NextCure
NXTC
$13.5M
– – -31,298 Closed -$86K